Megahed on the Effects of NGS on First-Line Treatment Decisi

Ahmed Megahed, MBBCh, discusses the rationale for investigating the effects of next-generation sequencing on first-line treatment decisions for patients with stage IV non–small cell lung cancer.

Related Keywords

Ahmed Megahed , Kaiser Permanente , Southern California Permanente Medical Group , Kaiser Permanente Southern California , Mbbch , Next Generation Sequencing , Patients With Stage Iv Non Small Cell Lung Cancer ,